Drug Profile
Research programme: phosphodiesterase IV inhibitors - CrystalGenomics
Alternative Names: PDE 4 inhibitors research programme - CrystalGenomics; Phosphodiesterase IV inhibitors research programme - CrystalGenomicsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator CrystalGenomics
- Class
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma